Quantum-si's new preprint showcases advances in protein variant detection using proteovue™ software with next-generation protein sequencing™

Branford, conn.--(business wire)--quantum-si incorporated (nasdaq: qsi) (“quantum-si,” “qsi” or the “company”), the protein sequencing company™, today announced a new paper that was submitted to biorxiv, demonstrating the capabilities of its proprietary bioinformatics tool called proteovue, for detecting and quantifying single amino acid variants (saavs). the paper, titled “detecting amino acid variants using next-generation protein sequencing (ngps),” highlights the transformative potential of.
QMCO Ratings Summary
QMCO Quant Ranking